In a filing, Moderna Inc revealed its Chief Executive Officer Bancel Stephane acquired Company’s shares for reported $5.0 million on Mar 03 ’25. In the deal valued at $31.22 per share,160,314 shares were bought. As a result of this transaction, Bancel Stephane now holds 9,210,686 shares worth roughly $286.64 million.
Then, SAGAN PAUL bought 31,620 shares, generating $1,004,251 in total proceeds. Upon buying the shares at $31.76, the Director now owns 312,027 shares.
Before that, Klinger Shannon Thyme sold 529 shares. Moderna Inc shares valued at $23,637 were divested by the Chief Legal Officer at a price of $44.68 per share. As a result of the transaction, Klinger Shannon Thyme now holds 20,446 shares, worth roughly $0.64 million.
Citigroup initiated its Moderna Inc [MRNA] rating to a Neutral in a research note published on March 13, 2025; the price target was $40. A number of analysts have revised their coverage, including Barclays’s analysts, who decreased its forecast for the stock in mid February from “an Overweight” to “an Equal weight”. Goldman also remained covering MRNA and has decreased its forecast on January 29, 2025 with a “Neutral” recommendation from previously “Buy” rating. Argus revised its rating on December 18, 2024. It rated MRNA as “a Hold” which previously was an “a Buy”.
Price Performance Review of MRNA
On Friday, Moderna Inc [NASDAQ:MRNA] saw its stock fall -3.11% to $31.12. Over the last five days, the stock has lost -4.72%. Moderna Inc shares have fallen nearly -25.16% since the year began. Nevertheless, the stocks have fallen -71.03% over the past one year. While a 52-week high of $170.47 was reached on 01/07/25, a 52-week low of $29.25 was recorded on 02/14/25. SMA at 50 days reached $34.74, while 200 days put it at $63.96.
Levels Of Support And Resistance For MRNA Stock
The 24-hour chart illustrates a support level at 30.59, which if violated will result in even more drops to 30.07. On the upside, there is a resistance level at 32.07. A further resistance level may holdings at 33.03. The Relative Strength Index (RSI) on the 14-day chart is 41.11, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.81, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.59%. Stochastics %K at 5.62% indicates the stock is a buying.
How much short interest is there in Moderna Inc?
A steep rise in short interest was recorded in Moderna Inc stocks on 2025-03-14, growing by 4.59 million shares to a total of 46.88 million shares. Yahoo Finance data shows the prior-month short interest on 2025-02-14 was 42.3 million shares. There was a rise of 9.78%, which implies that there is a positive sentiment for the stock.
